PROM1 and colonic neoplasm: Collectively all these data suggest that treatment of colon cancer cells with 5-Fluorouracil could potentially proliferate and select therapy resistant CD133 (+) colon CSLCs increasing the chances of tumor relapse and metastatic spread.